Our findings extend these observations by highlighting that modulation of growth factor receptor signaling, particularly EGFR, PDGFR, and VEGFR, may offer therapeutic benefit in reversing the CVB3-infected iBEC transcriptome during the later stages of infection. The gene discussed is PDGFRB; the disease is infection.